Details of the Drug

General Information of Drug (ID: DMVJL8W)

Drug Name
RG6299
Indication
Disease Entry ICD 11 Status REF
Geographic atrophy 9B75 Phase 2 [1]
IgA nephropathy MF8Y Phase 2 [1]
Drug Type
Antisense oligonucleotide
Cross-matching ID
TTD ID
DZ7Q8I
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Complement factor B (CFB) TTA0P7K CFAB_HUMAN Not Available [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

Molecular Expression Atlas of This Drug

The Studied Disease Geographic atrophy
ICD Disease Classification 9B75
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Complement factor B (CFB) DTT CFB 1.63E-02 0.07 0.13
Molecular Expression Atlas (MEA) Jump to Detail Molecular Expression Atlas of This Drug

References

1 Clinical pipeline report, company report or official report of Roche